Alzheimer’s disease Pathophysiology and Disease Mechanisms


Alzheimer’s disease (AD) is a progressive dementia with loss of neurons and the presence of two main microscopic neuropathological hallmarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, a rare familial form, is caused due to mutation of one out of three genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1).  Sporadic form occurs usually after age of 65 and accounts for most cases; it most likely results from a combination of genetic and influence of enviornment. Confirmed risk factors for sporadic AD are age and the presence of the E4 allele of (Apo lipoprotein E). Amyloid plaques comprise mainly of the neurotoxic peptide amyloid (Aβ, Abeta), cleaved sequentially from a larger precursor protein (APP) by two enzymes: β-secretase (also called BACE1) and γ-secretase (comprising four proteins, presenilin is one of them). If APP is first cleaved by the enzyme α-secretase rather than β-secretase then Aβ is not formed. Neurofibrillary tangles comprise mainly of the protein tau which binds with microtubules, which facilitating the neuronal transport system. Tau uncoupling from microtubules and aggregation into tangles inhibits transport and results in disassembly of microtubule. Phosphorylation of tau might have an important role in this. Selective vulnerability of neuronal systems such as the cholinergic, serotonergic, and noradrenergic and glutamatergic systems form the basis of current rational pharmacological treatment.



 


    Related Conference of Alzheimer’s disease Pathophysiology and Disease Mechanisms

    February 10-11, 2021

    2nd International Summit on Mental Disorders and Illness

    Amsterdam, Netherlands
    February 15-16, 2021

    Annual Congress on Psychiatry and Mental Health

    Toronto, Canada
    February 26-27, 2021

    38th Global Psychiatry and Mental Health Conference

    Rome, Italy
    March 17-18, 2021

    3rd European Autism Congress

    Paris, France
    April 21-22, 2021

    13th Worldwide Forum on Mental Health & Psychiatry

    Berlin, Germany
    May 07-08, 2021

    8th World Summit on Mental Health, Psychiatry and Wellbeing

    Amsterdam, Netherlands
    June 22-23, 2021

    32nd World Psychiatrists and Psychologists Meet

    Sydney, Australia
    July 20-21, 2021

    2 nd Annual Psychiatrists and Psychologists Meet

    Toronto, Canada
    October 25-26, 2021

    4th International Conference on Addiction & Psychiatry

    Amsterdam, Netherlands
    October 30-31, 2021

    2 nd Global Summit on Psychiatry and Psychotherapie

    Vancouver, Canada

    Alzheimer’s disease Pathophysiology and Disease Mechanisms Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in